| Cell line name | WIL2.NS.6TG |
|---|---|
| Synonyms | Wil2.NS.6TG |
| Accession | CVCL_2762 |
| Resource Identification Initiative | To cite this cell line use: WIL2.NS.6TG (RRID:CVCL_2762) |
| Comments | Group: Hybridoma fusion partner cell line. Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. |
| Sequence variations |
|
| Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_2761 (WIL2 NS) |
| Sex of cell | Male |
| Age at sampling | 5Y |
| Category | Transformed cell line |
| Cross-references | |
| Cell line collections (Providers) | ECACC; 93031001
NCBI_Iran; C148 |
| Cell line databases/resources | CLO; CLO_0009602
CLDB; cl4718 |
| Encyclopedic resources | Wikidata; Q54994067 |
| Entry history | |
| Entry creation | 04-Apr-2012 |
| Last entry update | 29-Jun-2023 |
| Version number | 17 |